RGEN FY 2014 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2014 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$64M-6.8% YoY

Gross Profit

$36M55.9% margin

Operating Income

$11M16.8% margin

Net Income

$8M12.9% margin

EPS (Diluted)

$0.25

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

-$65M

Total Liabilities

$17M

Stockholders' Equity

$112M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$68M	-6.8%
Gross Profit	$36M	$43M	-17.4%
Operating Income	$11M	$23M	-53.3%
Net Income	$8M	$16M	-49.2%